Effectiveness of medical device class 3 HAIRCARE in treatments androgenetic alopecia

Phase 3

Completed

• Conditions: Androgenic alopecia.; Androgenic alopecia

• Registration Number: IRCT20230401057792N1
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 24 June 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Men and women with hereditary hormonal hair loss

Exclusion Criteria

Severe allergic reaction to the injection
Receiving any topical or systemic medication in the last 3 months for hair loss

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The thickness of the hair. Timepoint: The third and sixth sessions and one month after the end of the treatment. Method of measurement: by the hair analyzer.;Hair density. Timepoint: The third and sixth sessions and one month after the end of the treatment. Method of measurement: by the hair analyzer.

Secondary Outcome Measures

Name	Time	Method
Patient satisfaction score of treatment. Timepoint: After the third and sixth sessions and one month after the treatment. Method of measurement: Based on patient global assessment score.;Doctor's satisfaction. Timepoint: After the third and sixth sessions and one month after the treatment. Method of measurement: Based on Physician global assessment score.;Tolerability of treatment. Timepoint: during treatment. Method of measurement: questionnaire.